Athletics Integrity Unit v. Titus Ekiru

Kenyan marathoner Titus Ekiru, the sixth-fastest marathon runner in history with a personal best of 2:02:57, tested positive twice within the same year: for triamcinolone acetonide after winning the Generali Milano Marathon on 16 May 2021, and for pethidine and its marker norpethidine after winning the ADNOC Abu Dhabi Marathon on 26 November 2021. In each case he initially explained the finding as the result of legitimate medical treatment, and was not immediately charged.

The AIU reopened the matter in 2022, working with the Anti-Doping Agency of Kenya, and provisionally suspended Ekiru on 28 June 2022. The resulting investigation went well beyond the two positive tests themselves. It found that Ekiru had received injections of triamcinolone acetonide from a senior doctor in Nandi County, Kenya, during undocumented hospital visits on 29 April and 6 May 2021, and a further undocumented visit on 19 November 2021 for a pethidine injection and tablets. According to the AIU, the doctor claimed Ekiru's visits went unrecorded because he attended before the hospital's registration offices opened each morning — an explanation the AIU said was contradicted by the hospital's own records, which showed the outpatient number Ekiru claimed to have used on his first two visits was not actually issued to him until 16 June 2021.

The AIU concluded that the medical documentation Ekiru submitted to explain both adverse findings had been forged, and charged him with two counts of tampering — using false or misleading information and documentation to obstruct its investigation — in addition to the two underlying substance violations. Testimony from the Nandi County Director of Medical Services proved decisive: it established that any medical documents purporting to record Ekiru's 29 April and 6 May 2021 treatments could only have been produced on or after 16 June 2021, the date his outpatient number was actually issued — meaning the documents were not merely inconsistent but literally backdated to a period before they could have existed. Facing the AIU's evidence, Ekiru, who had initially signalled his intention to contest the charges, dropped his case in July 2023 rather than pursue it before the Disciplinary Tribunal.

The AIU treated the two positive tests together with the first tampering charge as a single Anti-Doping Rule Violation, with the period of ineligibility set by whichever underlying charge carried the more severe standard sanction — here, the tampering violation's four-year default, rather than the presence charges' own default. The AIU then added two years for Aggravating Circumstances, citing specifically that Ekiru had committed multiple anti-doping rule violations, engaged in deceptive or obstructive conduct to avoid detection or adjudication, and engaged in tampering during results management itself, bringing that combined violation to six years. The second tampering charge, tied to his explanation for the second adverse finding, carried its own separate four-year sanction and was ordered to run consecutively. The combined sanction is a ten-year period of ineligibility running from 28 June 2022 to 27 June 2032. Both his Milan and Abu Dhabi results were annulled, including forfeiture of prize money, and his results and titles since 16 May 2021 were disqualified.

AIU chair David Howman's public statement on the decision was notably direct in addressing the entourage issue the case exposed: "For athletes involved in doping and the entourage who assist them, there is one strong message from this case — there is nowhere to hide." The doctor implicated in the case was not publicly named by the AIU but was referred to Kenyan authorities for further investigation.